Immunotherapy and radiotherapy in metastatic uveal melanoma: Results from a single institute study

被引：0
|
作者：
Guan, Jian
Teh, Bin S.
Schefler, Amy
Bernicker, Eric
机构：
[1] Houston Methodist Canc Ctr, Houston, TX USA
[2] Houston Methodist Hosp, Dept Radiat Oncol, Houston, TX USA
[3] Retina Consultants Texas, Bellaire, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21507
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study
    Rossi, Ernesto
    Zizzari, Ilaria Grazia
    Di Filippo, Alessandra
    Acampora, Anna
    Pagliara, Monica Maria
    Sammarco, Maria Grazia
    Simmaco, Maurizio
    Lionetto, Luana
    Botticelli, Andrea
    Bria, Emilio
    Marchetti, Paolo
    Blasi, Maria Antonietta
    Tortora, Giampaolo
    Schinzari, Giovanni
    Nuti, Marianna
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)
  • [42] STEREOTACTIC RADIOTHERAPY IN UVEAL MELANOMA: PRELIMINARY RESULTS FROM A QUEBEC CENTRE AFTER FOUR YEARS EXPERIENCE
    Caissie, A.
    Quinlan-Davidson, S.
    Corriveau, C.
    Edelstein, C.
    DeBlois, F.
    Shenouda, G.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S55 - S56
  • [43] Characterization of patients with brain metastases from metastatic uveal melanoma
    Muniz, T. Pimentel
    Koch, E. C.
    Ribeiro, M. F. Silva Almeida
    Silveira, M. T.
    Ceballos, D. P. Arteaga
    Jablonska, P. A.
    Mantle, L.
    Hirsch, I.
    Krema, H.
    Spreafico, A.
    Saibil, S.
    Hogg, D.
    Shultz, D.
    Butler, M. O.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S941 - S941
  • [44] A Pilot Study of Hepatic Irradiation with Yttrium90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
    Minor, David R.
    Kim, Kevin B.
    Tong, Ricky T.
    Wu, Max C.
    Kashani-Sabet, Mohammed
    Orloff, Marlana
    Eschelman, David J.
    Gonsalves, Carlin F.
    Adamo, Robert D.
    Anne, Pramila R.
    Luke, Jason J.
    Char, Devron
    Sato, Takami
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (01) : 11 - 16
  • [45] Immune checkpoint blockade for unresectable or metastatic uveal melanoma: results of a systematic review
    Heppt, M.
    Steeb, T.
    Schlager, J. G.
    Rosumeck, S.
    Dressler, C.
    Ruzicka, T.
    Nast, A.
    Berking, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 158 - 158
  • [46] Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: A single-institutional retrospective study
    Namikawa, K.
    Takahashi, A.
    Tsutsumida, A.
    Mori, T.
    Motoi, N.
    Jinnai, S.
    Kage, Y.
    Muto, Y.
    Nakano, E.
    Yamazaki, N.
    ANNALS OF ONCOLOGY, 2017, 28 : 114 - 114
  • [47] Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: a single-institution retrospective study
    Namikawa, Kenjiro
    Takahashi, Akira
    Mori, Taisuke
    Tsutsumida, Arata
    Suzuki, Shigenobu
    Motoi, Noriko
    Jinnai, Shunichi
    Kage, Yuta
    Mizuta, Haruki
    Muto, Yusuke
    Nakano, Eiji
    Yamazaki, Naoya
    MELANOMA RESEARCH, 2020, 30 (01) : 76 - 84
  • [48] Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study
    Vanaken, Lize
    Woei-A-Jin, F. J. Sherida H.
    Van Ginderdeuren, Rita
    Deroose, Christophe M.
    Laenen, Annouschka
    Missotten, Guy
    Thal, Dietmar R.
    Bechter, Oliver
    Schoffski, Patrick
    Clement, Paul
    ACTA ONCOLOGICA, 2023, 62 (05) : 480 - 487
  • [49] A Rare Thyroid Metastasis from Uveal Melanoma and Response to Immunotherapy Agents
    Collins, Dearbhaile Catherine
    Yela, Ruben
    Horgan, Noel
    Power, Derek Gerard
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2016, 2016
  • [50] Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
    Karivedu, Vidhya
    Eldessouki, Ihab
    Taftaf, Ahmad
    Zhu, Zheng
    Makramalla, Abouelmagd
    Karim, Nagla Abdel
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
12345